Astrocyte Pharmaceuticals to Develop Therapeutics for Brain Injury and Neurodegenerative Disease

Summary

The National Institute of Diabetes and Digestive and Kidney Diseases is considering granting an exclusive patent license to Astrocyte Pharmaceuticals to develop therapeutics for treating brain injury and neurodegenerative diseases, based on inventions described in several patent applications filed by the institute.